Literature Commentary. Issue 4 (December 2022)

• Record Type: Journal Article
• Editors: Moster, Mark L.; Dinkin, Marc J.; Friedman, Deborah I.
• Is Part Of: Journal of neuro-ophthalmology. Volume 42:Issue 4(2022)
• Page Start: e562
• Page End: e570
• Publication Date: 2022-12
• Subjects: Neuroophthalmology -- Periodicals; 617.7
• DOI: 10.1097/WNO.0000000000001747
• Languages: English
• ISSNs: 1070-8022

Abstract

Abstract : In this issue of Journal of Neuro-Ophthalmology, Drs. Marc J. Dinkin, Deborah I. Friedman, and Mark L. Moster discuss the following 6 articles: Mollan SP, Mitchell JL, Yiangou A, Ottridge RS, Alimajstorovic Z, Cartwright DM, Hickman SJ, Markey KA, Singhal R, Tahrani AA, Frew E, Brock K, Sinclair AJ. Association of amount of weight lost after bariatric surgery with intracranial pressure in women with idiopathic intracranial hypertension. Neurology. 2022;99. doi:10.1212/WNL.0000000000200839 . Nia AM, Srinivasan VM, Lall R, Kan P. Dural venous sinus stenting in idiopathic intracranial hypertension: a national database study of 541 patients. World Neurosurg. 2022:S1878-8750(22)01135-4. doi: 10.1016/j.wneu.2022.08.035 . Eide PK, Hansson HA. A new perspective on the pathophysiology of idiopathic intracranial hypertension: role of the glia-neuro-vascular interface. Front Mol Neurosci. 2022;15:900057. Shah S, Morris P, Buciuc M, Tajfirouz D, Wingerchuk DM, Weinshenker BG, Eggenberger ER, Di Nome M, Pittock SJ, Flanagan EP, Bhatti MT, Chen JJ. Frequency of asymptomatic optic nerve enhancement in a large retrospective cohort of patients with aquaporin-4+ NMOSD. Neurology. 2022;99:e851–e857. Bsteh G, Krajnc N, Riedl K, Altmann P, Kornek B, Leutmezer F, Macher S, Mitsch C, Pruckner P, Rommer PS, Zulehner G, Pemp B, Berger T; Vienna Multiple Sclerosis Database Study Group. Retinal layer thinning after optic neuritis is associated with future relapse remission in relapsing multiple sclerosis. Neurology. 2022. doi: 10.1212/WNL.0000000000200970 . Tsai RK, Lin KL, Huang CT, Wen YT. Transcriptomic analysis reveals that granulocyte colony-stimulating factor trigger a novel signaling pathway (TAF9-P53-TRIAP1-CASP3) to protect retinal ganglion cells after ischemic optic neuropathy. Int J Mol Sci. 2022;23:8359. doi: 10.3390/ijms23158359 .